Immune-mediated dormancy: an equilibrium with cancer

This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of leukocyte biology 2008-10, Vol.84 (4), p.988-993
Hauptverfasser: Teng, Michele W. L., Swann, Jeremy B., Koebel, Catherine M., Schreiber, Robert D., Smyth, Mark J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 993
container_issue 4
container_start_page 988
container_title Journal of leukocyte biology
container_volume 84
creator Teng, Michele W. L.
Swann, Jeremy B.
Koebel, Catherine M.
Schreiber, Robert D.
Smyth, Mark J.
description This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune‐mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.
doi_str_mv 10.1189/jlb.1107774
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69618621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69618621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4688-7d81265d656b00bdc7f9d8a0b36d23694949f5e1ff4a3a61b554cf18ca039a083</originalsourceid><addsrcrecordid>eNqFkLtPwzAQhy0EoqUwsaMssKDAOXb8YIOKR1ElFpgtJ3Goqzxau1HU_x5HqcQG8nCW7rvfnT6ELjHcYSzk_brKwgc45_QITbEkIiaMk2M0BU5xnFKACTrzfg0AJGFwiiZYpDglCZ8iuqjrrjFxbQqrd6aIitbVusn3D5FuIrPtbGUzZ7s66u1uFeWhZdw5Oil15c3Foc7Q18vz5_wtXn68LuaPyzinTIiYFwInLC1YyjKArMh5KQuhISOsSAiTNLwyNbgsqSaa4SxNaV5ikWsgUoMgM3Qz5m5cu-2M36na-txUlW5M23nFJMOCJfhfMAHJOSRD4u0I5q713plSbZyttdsrDGqwqYJNdbAZ6KtDbJcFQb_sQV8AYAR6W5n9X1nqffkEUgwXXI8jK_u96q0zyte6qsKGRPV9L6iiauB-AEviimI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20977028</pqid></control><display><type>article</type><title>Immune-mediated dormancy: an equilibrium with cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Teng, Michele W. L. ; Swann, Jeremy B. ; Koebel, Catherine M. ; Schreiber, Robert D. ; Smyth, Mark J.</creator><creatorcontrib>Teng, Michele W. L. ; Swann, Jeremy B. ; Koebel, Catherine M. ; Schreiber, Robert D. ; Smyth, Mark J.</creatorcontrib><description>This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune‐mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.</description><identifier>ISSN: 0741-5400</identifier><identifier>EISSN: 1938-3673</identifier><identifier>DOI: 10.1189/jlb.1107774</identifier><identifier>PMID: 18515327</identifier><language>eng</language><publisher>United States: Society for Leukocyte Biology</publisher><subject>Animals ; Disease Models, Animal ; elimination ; escape ; Humans ; Immune System ; immunoediting ; Interferon-gamma - immunology ; Interleukin-12 - immunology ; Mice ; Neoplasms - immunology ; Neoplasms - pathology ; Neovascularization, Pathologic - immunology ; T-Lymphocytes - immunology ; Tumor Escape - immunology</subject><ispartof>Journal of leukocyte biology, 2008-10, Vol.84 (4), p.988-993</ispartof><rights>2008 Society for Leukocyte Biology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4688-7d81265d656b00bdc7f9d8a0b36d23694949f5e1ff4a3a61b554cf18ca039a083</citedby><cites>FETCH-LOGICAL-c4688-7d81265d656b00bdc7f9d8a0b36d23694949f5e1ff4a3a61b554cf18ca039a083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1189%2Fjlb.1107774$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1189%2Fjlb.1107774$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18515327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teng, Michele W. L.</creatorcontrib><creatorcontrib>Swann, Jeremy B.</creatorcontrib><creatorcontrib>Koebel, Catherine M.</creatorcontrib><creatorcontrib>Schreiber, Robert D.</creatorcontrib><creatorcontrib>Smyth, Mark J.</creatorcontrib><title>Immune-mediated dormancy: an equilibrium with cancer</title><title>Journal of leukocyte biology</title><addtitle>J Leukoc Biol</addtitle><description>This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune‐mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.</description><subject>Animals</subject><subject>Disease Models, Animal</subject><subject>elimination</subject><subject>escape</subject><subject>Humans</subject><subject>Immune System</subject><subject>immunoediting</subject><subject>Interferon-gamma - immunology</subject><subject>Interleukin-12 - immunology</subject><subject>Mice</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - pathology</subject><subject>Neovascularization, Pathologic - immunology</subject><subject>T-Lymphocytes - immunology</subject><subject>Tumor Escape - immunology</subject><issn>0741-5400</issn><issn>1938-3673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLtPwzAQhy0EoqUwsaMssKDAOXb8YIOKR1ElFpgtJ3Goqzxau1HU_x5HqcQG8nCW7rvfnT6ELjHcYSzk_brKwgc45_QITbEkIiaMk2M0BU5xnFKACTrzfg0AJGFwiiZYpDglCZ8iuqjrrjFxbQqrd6aIitbVusn3D5FuIrPtbGUzZ7s66u1uFeWhZdw5Oil15c3Foc7Q18vz5_wtXn68LuaPyzinTIiYFwInLC1YyjKArMh5KQuhISOsSAiTNLwyNbgsqSaa4SxNaV5ikWsgUoMgM3Qz5m5cu-2M36na-txUlW5M23nFJMOCJfhfMAHJOSRD4u0I5q713plSbZyttdsrDGqwqYJNdbAZ6KtDbJcFQb_sQV8AYAR6W5n9X1nqffkEUgwXXI8jK_u96q0zyte6qsKGRPV9L6iiauB-AEviimI</recordid><startdate>20081001</startdate><enddate>20081001</enddate><creator>Teng, Michele W. L.</creator><creator>Swann, Jeremy B.</creator><creator>Koebel, Catherine M.</creator><creator>Schreiber, Robert D.</creator><creator>Smyth, Mark J.</creator><general>Society for Leukocyte Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20081001</creationdate><title>Immune-mediated dormancy: an equilibrium with cancer</title><author>Teng, Michele W. L. ; Swann, Jeremy B. ; Koebel, Catherine M. ; Schreiber, Robert D. ; Smyth, Mark J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4688-7d81265d656b00bdc7f9d8a0b36d23694949f5e1ff4a3a61b554cf18ca039a083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Disease Models, Animal</topic><topic>elimination</topic><topic>escape</topic><topic>Humans</topic><topic>Immune System</topic><topic>immunoediting</topic><topic>Interferon-gamma - immunology</topic><topic>Interleukin-12 - immunology</topic><topic>Mice</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - pathology</topic><topic>Neovascularization, Pathologic - immunology</topic><topic>T-Lymphocytes - immunology</topic><topic>Tumor Escape - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teng, Michele W. L.</creatorcontrib><creatorcontrib>Swann, Jeremy B.</creatorcontrib><creatorcontrib>Koebel, Catherine M.</creatorcontrib><creatorcontrib>Schreiber, Robert D.</creatorcontrib><creatorcontrib>Smyth, Mark J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of leukocyte biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teng, Michele W. L.</au><au>Swann, Jeremy B.</au><au>Koebel, Catherine M.</au><au>Schreiber, Robert D.</au><au>Smyth, Mark J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune-mediated dormancy: an equilibrium with cancer</atitle><jtitle>Journal of leukocyte biology</jtitle><addtitle>J Leukoc Biol</addtitle><date>2008-10-01</date><risdate>2008</risdate><volume>84</volume><issue>4</issue><spage>988</spage><epage>993</epage><pages>988-993</pages><issn>0741-5400</issn><eissn>1938-3673</eissn><abstract>This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune‐mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.</abstract><cop>United States</cop><pub>Society for Leukocyte Biology</pub><pmid>18515327</pmid><doi>10.1189/jlb.1107774</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5400
ispartof Journal of leukocyte biology, 2008-10, Vol.84 (4), p.988-993
issn 0741-5400
1938-3673
language eng
recordid cdi_proquest_miscellaneous_69618621
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Disease Models, Animal
elimination
escape
Humans
Immune System
immunoediting
Interferon-gamma - immunology
Interleukin-12 - immunology
Mice
Neoplasms - immunology
Neoplasms - pathology
Neovascularization, Pathologic - immunology
T-Lymphocytes - immunology
Tumor Escape - immunology
title Immune-mediated dormancy: an equilibrium with cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T01%3A05%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune-mediated%20dormancy:%20an%20equilibrium%20with%20cancer&rft.jtitle=Journal%20of%20leukocyte%20biology&rft.au=Teng,%20Michele%20W.%20L.&rft.date=2008-10-01&rft.volume=84&rft.issue=4&rft.spage=988&rft.epage=993&rft.pages=988-993&rft.issn=0741-5400&rft.eissn=1938-3673&rft_id=info:doi/10.1189/jlb.1107774&rft_dat=%3Cproquest_cross%3E69618621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20977028&rft_id=info:pmid/18515327&rfr_iscdi=true